Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT)
    Meeting Abstract

    Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • JANUS 2: A phase III study of survival, tumor response, and symptom response with ruxolitinib plus capecitabine or placebo plus capecitabine in patients with advanced or metastatic pancreatic cancer (mPC) who failed or were intolerant to first-line chemotherapy
    Meeting Abstract

    O'Reilly, E. M.; Walker, C.; Clark, J.; Brill, K. J.; Dawkins, F. W.; Bendell, J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase 1 results
    Meeting Abstract

    O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Schultes, B. C.; Rosano, M. E.; Miller, P. J.; Wolf, J.; Flaherty, K.; Ryan, D. P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma (HCC) and bone metastases (Mets)
    Meeting Abstract

    Harding, J. J.; Abu Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; O'Reilly, E. M.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • "Months, not years": Impact of clinical discussions of advanced cancer life-expectancy on patient illness understanding
    Meeting Abstract

    Epstein, A. S.; Prigerson, H. G.; Saltz, L.; O'Reilly, E. M.; Shah, M. A.; Maciejewski, P. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of chemotherapy on hospitalizations and emergency care in older adults with advanced cancer
    Meeting Abstract

    Elkin, E. B.; O'neill, C.; Atoria, C. L.; O'Reilly, E. M.; Bach, P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Platinum-based combination therapy (PCT) and outcomes for patients (pts) with mixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma (mHCC/ICC)
    Meeting Abstract

    Connell, L. C.; Harding, J. J.; Lowery, M. A.; Kemeny, N. E.; Cercek, A.; Abdelgawad, M. I.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Novel therapeutics for pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; O'Reilly, E. M.
    Hematology/Oncology Clinics of North America (2015)

    Fulltext@MSK | Save
  • 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
    Journal Article

    Picozzi, V. J.; Ramanathan, R. K.; Lowery, M. A.; Ocean, A. J.; Mitchel, E. P.; O'Neil, B. H.; Guarino, M. J.; Conkling, P. R.; Cohen, S. J.; Bahary, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save